A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
Clinical trial NCT03605680 · COMPLETED
Trial details
- NCT number
- NCT03605680
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-16
- Primary completion
- 2020-04-11
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.